This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000; 14: 2205-22. 10.1038/sj.leu.2401973SchrappeMReiterAZimmermannMHarbottJLudwigWDHenzeGLong-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995Leukemia20001422052210.1038/sj.leu.2401973Open DOISearch in Google Scholar
Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J clin Oncol 2014; 32: 174-84. 10.1200/JCO.2013.48.6522StaryJZimmermannMCampbellMCastilloLDibarEDonskaSIntensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002J clin Oncol2014321748410.1200/JCO.2013.48.6522Open DOISearch in Google Scholar
Rudin S, Marable M, Huang RS. The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment. Genomics, Proteomics, Bioinformatics 2017; 15: 82-93. 10.1016/j.gpb.2016.11.003RudinSMarableMHuangRS.The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatmentGenomics, Proteomics, Bioinformatics201715829310.1016/j.gpb.2016.11.003Open DOISearch in Google Scholar
Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14: 452-60.HelmbergAAuphanNCaellesCKarinM.Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptorEMBO J1995144526010.1002/j.1460-2075.1995.tb07021.xSearch in Google Scholar
Campbell M. ALL IC-BFM 2009 a randomized trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia. 2009; 178.CampbellM.ALL IC-BFM 2009 a randomized trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia.2009178Search in Google Scholar
Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004; 11: S45-55. 10.1038/sj.cdd.4401456SchmidtSRainerJPlonerCPresulERimlSKoflerR.Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevanceCell Death Differ200411455510.1038/sj.cdd.4401456Open DOISearch in Google Scholar
Koper JW, Van Rossum EFC, Van Den Akker ELT. Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and disease. Steroids 2014; 92: 62-73. 10.1016/j.steroids.2014.07.015KoperJWVan RossumEFCVan Den AkkerELT.Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and diseaseSteroids201492627310.1016/j.steroids.2014.07.015Open DOISearch in Google Scholar
DeRijk RH, Schaaf M, De Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 2002; 81: 103-22. 10.1016/S0960-0760(02)00062-6DeRijkRHSchaafMDe Kloet ER. Glucocorticoid receptor variants: clinical implicationsJ Steroid Biochem Mol Biol2002811032210.1016/S0960-0760(02)00062-6Open DOISearch in Google Scholar
Eipel OT, Németh K, Török D, Csordás K, Hegyi M, Ponyi A, et al. The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy. Int J Hematol 2013; 97: 216-22. 10.1007/s12185-012-1236-1EipelOTNémethKTörökDCsordásKHegyiMPonyiAThe glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapyInt J Hematol2013972162210.1007/s12185-012-1236-123355259Open DOISearch in Google Scholar
Tissing WJE. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res 2005; 11: 6050-56. 10.1158/1078-0432.CCR-04-2097TissingWJE.Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemiaClin Cancer Res20051160505610.1158/1078-0432.CCR-04-209716115950Open DOISearch in Google Scholar
Xue L, Li C, Wang Y, Sun W, Ma C, He Y, et al. Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2015; 56: 1704-09. 10.3109/10428194.2014.951848XueLLiCWangYSunWMaCHeYSingle nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemiaLeuk Lymphoma20155617040910.3109/10428194.2014.951848Open DOISearch in Google Scholar
Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285-98. 10.1038/nrg775CartegniLChewSLKrainerAR.Listening to silence and understanding nonsense: Exonic mutations that affect splicingNat Rev Genet200232859810.1038/nrg775Open DOISearch in Google Scholar
Gross KL, Lu NZ, Cidlowski JA. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol 2009; 300: 7-16. 10.1016/j.mce.2008.10.001.MolecularGrossKLLuNZCidlowskiJA.Molecular mechanisms regulating glucocorticoid sensitivity and resistanceMol Cell Endocrinol200930071610.1016/j.mce.2008.10.001.MolecularOpen DOISearch in Google Scholar
Zalewski G, Wasilewska A, Zoch-Zwierz W, Chyczewski L. Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol 2008; 23: 1073-8. 10.1007/s00467-008-0772-7ZalewskiGWasilewskaAZoch-ZwierzWChyczewskiL.Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndromePediatr Nephrol2008231073810.1007/s00467-008-0772-7Open DOISearch in Google Scholar
Schaaf MJM, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002; 83: 37-48. 10.1016/S0960-0760(02)00263-7SchaafMJMhCidlowskiJA.Molecular mechanisms of glucocorticoid action and resistanceJ Steroid Biochem Mol Biol200283374810.1016/S0960-0760(02)00263-7Open DOISearch in Google Scholar
Derijk RH, Schaaf MJ, Turner G, Datson Na, Vreugdenhil E, Cidlowski J, et al. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001; 28: 2383-8.DerijkRHSchaafMJTurnerGDatsonNaVreugdenhilECidlowskiJA human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritisJ Rheumatol20012823838Search in Google Scholar
Vega L. 3. Role of glutathione S-transferase enzymes in toxicology, pharmacology and human disease. Pharmacological and Toxicological Aspects 2010; 661: 45-66.VegaL.3. Role of glutathione S-transferase enzymes in toxicology, pharmacology and human diseasePharmacological and Toxicological Aspects20106614566Search in Google Scholar
Homma H, Listowsky I. Identification of Yb-glutathione-S-transferase as a major rat liver protein labeled with dexamethasone 21-methanesulfonate. Proc Natl Acad Sci U S A 1985; 82: 7165-69. 10.2307/26329HommaHListowskyI.Identification of Yb-glutathione-S-transferase as a major rat liver protein labeled with dexamethasone 21-methanesulfonateProc Natl Acad Sci U S A19858271656910.2307/26329Open DOISearch in Google Scholar
Johansson AS, Stenberg G, Widersten M, Mannervik B. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 1998; 278: 687-98. 10.1006/jmbi.1998.1708JohanssonASStenbergGWiderstenMMannervikB.Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105J Mol Biol19982786879810.1006/jmbi.1998.17089600848Open DOISearch in Google Scholar
Zubowska M, Zielińska E, Zmysłowska A, Bodalski J. [Increased frequency of A-G transition at exon 5 of GSTP1 as a genetic risk factor for acute childhood leukaemia]. [Polish]. Med Wieku Rozwoj 2004; 8: 245-57.ZubowskaMZielińskaEZmystowskaABodalskiJ.[Increased frequency of A-G transition at exon 5 of GSTP1 as a genetic risk factor for acute childhood leukaemia]. [Polish]Med Wieku Rozwoj2004824557Search in Google Scholar
Farrell RJ, Menconi MJ, Keates AC, Kelly CP. P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes. Aliment Pharmacol Ther 2002; 16: 1021-31. 10.1046/j.1365-2036.2002.01238.xFarrellRJMenconiMJKeatesACKellyCP.P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytesAliment Pharmacol Ther20021610213110.1046/j.1365-2036.2002.01238.x11966513Open DOISearch in Google Scholar
Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97: 3473-8. 10.1073/pnas.050585397HoffmeyerSBurkOvon RichterOArnoldHPBrockmöllerJJohneAFunctional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProc Natl Acad Sci U S A2000973473810.1073/pnas.050585397Open DOISearch in Google Scholar
Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361-98. 10.1146/annurev.pharmtox.39.1.361AmbudkarSVDeySHrycynaCARamachandraMPastanIGottesmanMM.Biochemical, cellular, and pharmacological aspects of the multidrug transporterAnnu Rev Pharmacol Toxicol1999393619810.1146/annurev.pharmtox.39.1.36110331089Open DOISearch in Google Scholar
Wasilewska A, Zoch-Zwierz W, Pietruczuk M, Zalewski G. Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol 2006; 21: 1274-80. 10.1007/s00467-006-0187-2WasilewskaAZoch-ZwierzWPietruczukMZalewskiG.Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid responsePediatr Nephrol20062112748010.1007/s00467-006-0187-2Open DOISearch in Google Scholar
Smith LK, Cidlowski JA. Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes. Prog Brain Res 2010; 182: 1-30. 10.1016/S0079-6123(10)82001-1SmithLKCidlowskiJA.Glucocorticoid-induced apoptosis of healthy and malignant lymphocytesProg Brain Res201018213010.1016/S0079-6123(10)82001-1Open DOISearch in Google Scholar
Meissner B, Stanulla M, Ludwig W-D, Harbott J, Möricke a, Welte K, et al. The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia. Leukemia 2004; 18: 1920-3. 10.1038/sj.leu.2403521MeissnerBStanullaMLudwigW-DHarbottJMörickeaWelteKThe GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemiaLeukemia2004181920310.1038/sj.leu.240352115457183Open DOISearch in Google Scholar
Vaghela N, Anand IS, Trivedi DH, Jani M. Prognostic value of peripheral blood blast percentage on day 8 in long term cure in patients with ALL. World J Pharmacy Pharm Sci 2014; 3: 1839-47.VaghelaNAnandISTrivediDHJaniM.Prognostic value of peripheral blood blast percentage on day 8 in long term cure in patients with ALLWorld J Pharmacy Pharm Sci20143183947Search in Google Scholar
Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-91.ChenCLLiuQRellingMV.Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksPharmacogenetics199661879110.1097/00008571-199604000-000059156696Search in Google Scholar
Kurzawski M, Pawlik A, Górnik W, Droździk M. Frequency of common MDR1 gene variants in a Polish population. Pharmacol Rep 2006; 58: 35-40.KurzawskiMPawlikAGórnikWDroździk M. Frequency of common MDR1 gene variants in a Polish populationPharmacol Rep2006583540Search in Google Scholar
Excoffier L, Lischer HEL. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010; 10: 564-67. 10.1111/j.1755-0998.2010.02847.xExcoffierLLischer HEL. Arlequin suite ver 3.5 a new series of programs to perform population genetics analyses under Linux and WindowsMol Ecol Resour2010105646710.1111/j.1755-0998.2010.02847.x21565059Open DOISearch in Google Scholar
Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, et al. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther Drug Monit 2006; 28: 800-06. 10.1097/01.ftd.0000249947.17676.92DokmanovicLUrosevicJJanicDJovanovicNPetrucevBTosicNAnalysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemiaTher Drug Monit2006288000610.1097/01.ftd.0000249947.17676.9217164697Open DOISearch in Google Scholar
Jackson RK, Irving JAE, Veal GJ. Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia. Br J Haematol 2016; 173: 13-24. 10.1111/bjh.13924JacksonRKIrving JAE, Veal GJ. Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemiaBr J Haematol2016173132410.1111/bjh.1392426729065Open DOISearch in Google Scholar
Asselin BL. The right dose for the right patient. Blood 2012; 119: 1617-8. 10.1182/blood-2011-12-395855AsselinBL.The right dose for the right patientBlood20121191617810.1182/blood-2011-12-39585522343660Open DOISearch in Google Scholar
Labuda M, Gahier A, Gagné V, Moghrabi A, Sinnett D, Krajinovic M. Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL). Leuk Res 2010; 34: 492-97. 10.1016/j.leukres.2009.08.007LabudaMGahierAGagnéVMoghrabiASinnettDKrajinovicM.Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL)Leuk Res2010344929710.1016/j.leukres.2009.08.00719758697Open DOISearch in Google Scholar
Stanulla M, Schrappe M, Brechlin AM, Zimmermann M, Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood 2000; 95: 1222-8.StanullaMSchrappeMBrechlinAMZimmermannMWelteK.Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control studyBlood2000951222810.1182/blood.V95.4.1222.004k20_1222_1228Search in Google Scholar
Stanulla M, Schäffeler E, Arens S, Rathmann A, Schrauder A, Welte K, et al. GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia. Int J Hematol 2005; 81: 39-44.StanullaMSchäffelerEArensSRathmannASchrauderAWelteKGSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemiaInt J Hematol200581394410.1532/IJH97.E0418Search in Google Scholar
Franca R, Rebora P, Basso G, Biondi A, Cazzaniga G, Crovella S, et al. Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. Pharmacogenomics 2012; 13: 1905-16. 10.2217/pgs.12.169FrancaRReboraPBassoGBiondiACazzanigaGCrovellaSGlutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohortPharmacogenomics20121319051610.2217/pgs.12.16923215883Open DOISearch in Google Scholar
Longui CA, Vottero A, Adamson PC, Cole DE, Chrousos GP. Low glucocorticoid receptor alpha/beta ratio in T-ceII lymphoblastic leukemia. Horm Metab Res 2000; 32: 401-6. 10.1055/s-2007-978661LonguiCAVotteroAAdamsonPCColeDEChrousos GP Low glucocorticoid receptor alpha/beta ratio in T-ceII lymphoblastic leukemiaHorm Metab Res200032401610.1055/s-2007-97866111069204Open DOISearch in Google Scholar
Turner JD, Schote AB, Macedo JA, Pelascini LPL, Muller CP. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochem Pharmacol 2006; 72: 1529-37. 10.1016/j.bcp.2006.07.005TurnerJDSchoteABMacedoJAPelascini LPL, Muller CP. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?Biochem Pharmacol20067215293710.1016/j.bcp.2006.07.00516930562Open DOISearch in Google Scholar
Bamberger CM, Bamberger AM, De Castro M, Chrousos GP. Glucocorticoid receptor B, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995; 95: 2435-41. 10.1172/JCI117943BambergerCMBambergerAMDe CastroMChrousosGP.Glucocorticoid receptorBa potential endogenous inhibitor of glucocorticoid action in humansJ Clin Invest19959524354110.1172/JCI1179432959157769088Open DOISearch in Google Scholar
Koga Y, Matsuzaki A, Suminoe A, Hattori H, Kanemitsu S, Hara T. Differential mRNA expression of glucocorticoid receptor α and β is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 2005; 45: 121-27. 10.1002/pbc.20308KogaYMatsuzakiASuminoeAHattoriHKanemitsuSHaraT.Differential mRNA expression of glucocorticoid receptor α and β is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in childrenPediatr Blood Cancer2005451212710.1002/pbc.2030815704223Open DOISearch in Google Scholar
Teeninga N, Kist-Van Holthe JE, Van Den Akker ELT, Kersten MC, Boersma E, Krabbe HG, et al. Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome. Kidney Int 2014; 85: 1444-53. 10.1038/ki.2013.531TeeningaNKist-Van HoltheJEVan Den AkkerELTKerstenMCBoersmaEKrabbeHGGenetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndromeKidney Int20148514445310.1038/ki.2013.53124429396Open DOISearch in Google Scholar
Kumsta R, Moser D, Streit F, Koper JW, Meyer J, Wüst S. Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance. Am J Med Genet B Neuropsychiatr Genet 2009; 150: 476-82. 10.1002/ajmg.b.30837KumstaRMoserDStreitFKoperJWMeyerJWüst S. Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevanceAm J Med Genet B Neuropsychiatr Genet20091504768210.1002/ajmg.b.3083718663733Open DOISearch in Google Scholar
Beger C, Gerdes K, Lauten M, Tissing WJE, Fernandez-Munoz I, Schrappe M, et al. Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 2003; 122: 245-52. 10.1046/j.1365-2141.2003.04426.xBegerCGerdesKLautenMTissingWJEFernandez-MunozISchrappeMExpression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approachBr J Haematol20031222455210.1046/j.1365-2141.2003.04426.x12846893Open DOISearch in Google Scholar
Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CEM, et al. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab 2004; 89: 892-97. 10.1210/jc.2003-031235StevensARayDWZegginiEJohnSRichardsHLGriffithsCEMGlucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotypeJ Clin Endocrinol Metab2004898929710.1210/jc.2003-03123514764810Open DOISearch in Google Scholar
Pearce KF, Balavarca Y, Norden J, Jackson G, Holler E, Dressel R, et al. Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia. Int J Immunogenet 2016; 43: 404-12. 10.1111/iji.12295PearceKFBalavarcaYNordenJJacksonGHollerEDresselRImpact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemiaInt J Immunogenet2016434041210.1111/iji.1229527870355Open DOISearch in Google Scholar
Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K, et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000; 10: 715-26. 10.1097/00008571-200011000-00006AndererGSchrappeMBrechlinAMLautenMMutiPWelteKPolymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemiaPharmacogenetics2000107152610.1097/00008571-200011000-0000611186134Open DOISearch in Google Scholar
Jafar T, Prasad N, Agarwal V, Mahdi A, Gupta A, Sharma RK, et al. MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children. Nephro Dial Transplant 2011; 26: 3968-74. 10.1093/ndt/gfr150JafarTPrasadNAgarwalVMahdiAGuptaASharmaRKMDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in childrenNephro Dial Transplant20112639687410.1093/ndt/gfr15021460357Open DOISearch in Google Scholar
Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics 2005; 15: 693-704. 10.1097/01.fpc.0000178311.02878.83WangDJohnsonADPappACKroetzDLSadéeW.Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stabilityPharmacogenet Genomics20051569370410.1097/01.fpc.0000178311.02878.83Open DOISearch in Google Scholar
Xuan M, Li H, Fu R, Yang Y, Zhang D, Zhang X, et al. Association of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopenia. Hum Immunol 2014; 75: 317-21. 10.1016/j.humimm.2014.01.013XuanMLiHFuRYangYZhangDZhangXAssociation of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopeniaHum Immunol2014753172110.1016/j.humimm.2014.01.01324486577Open DOISearch in Google Scholar
Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med 2015; 373: 1541-52. 10.1056/NEJMra1400972HungerSPMullighanCG.Acute lymphoblastic leukemia in childrenN Engl J Med201537315415210.1056/NEJMra140097226465987Open DOISearch in Google Scholar
Dokmanovic L, Milosevic G, Peric J, Tosic N, Krstovski N, Janic D, et al. Next generation sequencing as a tool for pharmacogenomic profiling: Nine novel potential genetic markers for targeted therapy in childhood acute lymphoblastic leukemia. Srp Arh Celok Lek 2017; 145: 194-94. 10.2298/SARH171003194DDokmanovicLMilosevicGPericJTosicNKrstovskiNJanicDNext generation sequencing as a tool for pharmacogenomic profiling: Nine novel potential genetic markers for targeted therapy in childhood acute lymphoblastic leukemiaSrp Arh Celok Lek20171451949410.2298/SARH171003194DOpen DOISearch in Google Scholar
